✦ LIBER ✦

Breakpoint zone of bcr in chronic myelogenous leukemia does not correlate with disease phase or prognosis

✍ Scribed by Donna Przepiorka

Book ID: 119103816
Publisher: Elsevier Science
Year: 1988
Tongue: English
Weight: 287 KB
Volume: 36
Category: Article
ISSN: 0165-4608
DOI: 10.1016/0165-4608(88)90081-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The position of the M-BCR breakpoint doe

The position of the M-BCR breakpoint does not predict the duration of chronic phase or survival in chronic myeloid leukaemia

✍ Jerome Jaubert; Philippe Martiat; Charles Dowding; Norbert Ifrah; John M. Goldma 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 552 KB

Chromosome and bcr rearrangement in chro

Chromosome and bcr rearrangement in chronic myelogenous leukaemia and their correlation with clinical states and prognosis of the disease

✍ H. F. Tien; C. H. Wang; Y. C. Chen; M. C. Shen; H. S. Wu; F. Y. Lee; S. M. Chuan 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 882 KB

Bone marrow dysplasia in patients with n

Bone marrow dysplasia in patients with newly diagnosed acute myelogenous leukemia does not correlate with history of myelodysplasia or with remission rate and survival

✍ Karen K. Ballen; D. Gary Gilliland; Leslie A. Kalish; Lawrence N. Shulman 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 634 KB

Background. The records and initial bone marrow studies of 106 patients with newly diagnosed acute myelogenous leukemia (AML) were analyzed retrospectively to determine whether bone marrow dysplasia was predictive of a previous myelodysplastic disorder or correlated with remission rate and survival.

Mechanisms of genesis of variant translo

Mechanisms of genesis of variant translocation in chronic myeloid leukemia are not correlated with ABL1 or BCR deletion status or response to imatinib therapy

✍ Steven Richebourg; Virginie Eclache; Christine Perot; Marie-France Portnoi; Jacq 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 674 KB

The G(-248)A polymorphism in the promote

The G(-248)A polymorphism in the promoter region of the Bax gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukemia

✍ Skogsberg, Å; Tobin, G; Kröber, A; Kienle, D; Thunberg, U; Åleskog, A; Karlsson, 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 153 KB

Prior treatment with the tyrosine kinase

Prior treatment with the tyrosine kinase inhibitors dasatinib and nilotinib allows stem cell transplantation (SCT) in a less advanced disease phase and does not increase SCT Toxicity in patients with chronic myelogenous leukemia and philadelphia positive acute lymphoblastic leukemia

✍ Shimoni, A; Leiba, M; Schleuning, M; Martineau, G; Renaud, M; Koren-Michowitz, M 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 103 KB